FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+13.67%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$247M
AUM Growth
+$247M
(+13%)
Cap. Flow
+$12M
Cap. Flow
% of AUM
4.88%
Top 10 Holdings %
Top 10 Hldgs %
99.51%
Holding
17
New
4
Increased
1
Reduced
4
Closed
5
Top Buys
1 |
Insmed
INSM
|
$9.36M |
2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.13M |
3 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$4.04M |
4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$1.32M |
5 |
EPZM
Epizyme, Inc
EPZM
|
$1.11M |
Top Sells
1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$4.27M |
2 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$4.2M |
3 |
DERM
Dermira, Inc.
DERM
|
$2.07M |
4 |
Akebia Therapeutics
AKBA
|
$719K |
5 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$591K |
Sector Composition
1 | Healthcare | 26.38% |